sofar life fructan style gojoli integratore alimentare 20 bustine
sofar spa -
blincyto
amgen europe b.v. - blinatumomab - linfoma di leucemia linfoblastica a cellule precursori - agenti antineoplastici - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.
miringotomo
invotec international inc. - lame monouso per otorinolaringoiatria
myringotomy blade disp, tapered shaft/straight edg
gyrus acmi inc - lame monouso per otorinolaringoiatria
nix
perrigo italia s.r.l. - piretrine, inclusi i composti sintetici - piretrine, inclusi i composti sintetici
bactrim
eumedica pharmaceuticals gmbh - associazioni di sulfamidici con trimetoprim, inclusi i derivati - associazioni di sulfamidici con trimetoprim, inclusi i derivati
omegoil
ibsa farmaceutici italia s.r.l. - omega-3-trigliceridi inclusi altri esteri e acidi - omega-3-trigliceridi inclusi altri esteri e acidi
zolpidem cr zentiva 6,25 mg compresse controllata principio attivo di condivisione
helvepharm ag - zolpidemi tartras - compresse controllata principio attivo di condivisione - zolpidemi tartras 6.25 mg, lactosum monohydricum 138,9 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, hypromellosum, magnesii stearas, silica colloidalis anhydrica, kalii hydrogenotartras, macrogolum 3350, e 171, e 172 (rubrum), pro compresso obducto corresp. natrium max. 0.25 mg. - hypnoticum - synthetika